¹Junior Resident, ²Professor, Department of Medicine, Patna Medical College and Hospital, Bihar, INDIA.

Email: dranand21@gmail.com

REFERENCES

1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–43.
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685–95.
3. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, 3rd, Criqui M, et al.. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499–511.
4. Keller T, Zeller T, Peetz D, et al.. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med. 2009;361(9):868–877
5. Omland T, de Lemos JA, Sabatine MS, et al.. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med. 2009;361(26):2538–2547.
6. Moran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Flaxman A, Murray CJ, Naghavi M (April 2014). "The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study". Circulation. 129 (14): 1493– 501.
7. Devlin RJ, Henry JA (2008). "Clinical review: Major consequences of illicit drug consumption". Critical Care. 12(1): 202.
8. "How Is a Heart Attack Diagnosed?". www.nhlbi.nih.gov. December 17, 2013. A rchived from the original on 24 February 2015. Retrieved 24 February 2015.
9. Casas JP, Shah T, Hingorani AD, Danesh J, Pepys MB (2008) C-reactive protein and coronary heart disease: a critical review. J Intern Med 264: 295-314.
10. Ohman EM, Armstrong PW, Christenson RH, et al.. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med. 1996;335(18):1333–1341.
11. Morrow DA, Cannon CP, Jesse RL, et al.. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem. 2007;53(4):552–574.
12. Gurunani RH, Shrivastav A, Maru AM, Choksi TS, Agnihotri AS. Correlation of high sensitive C-reactive protein with cardiac markers in the diagnosis of acute coronary artery disease: A study of 100 cases. Med J DY Patil Univ 2015;8:614-8.
13. Chow C, Pell A, Walker A, O'Dowd C, Dominiczak A, Pell J. Families of patients with premature coronary heart disease: an obvious but neglected target for primary prevention. BMJ. 2007;335(7618):481–485.
14. Akbari M, Mohammadzadeh M, Rajabpoor M, AzimPoor A. Agents connection with awareness and act of patients that caused acute myocardial infarction encountering with clinical symptoms them to stay in urmia hospitals. Journal of Urmia Nursing And Midwifery Faculty. 2009;7(2):73–80. 
15. Birnbaum Y, Drew BJ. The electrocardiogram in ST elevation acute myocardial infarction: correlation with coronary anatomy and prognosis. Postgrad Med J 2003;79:490-504. 10.1136/pmj.79.935.490.
16. Zimetbaum PJ, Josephson ME. Use of the electrocardiogram in acute myocardial infarction. N Engl J Med 2003;348:933-40. 10.1056/NEJMra022700.
17. Gorecki A, Bednarz B, Jaxa-Chamiec T, et al.. Lipid profile during the first 24 hours after myocardial infarction has significant prognostic value. Kardiol Pol. 2004;60:229–36.
18. Akosah KO, Cerniglia RM, Havlik P, Schaper A. Myocardial infarction in young adults with low-density lipoprotein cholesterol levels ≤ 100 mg/dL: clinical profile and 1-year outcomes. Chest. 2001;120:1953–8.
19. Davidson MH, Toth PP. High-density lipoprotein metabolism: potential therapeutic targets. Am J Cardiol. 2007;100:n32–40. 
20. Al Aqeel A, Mojiminiyi OA, Al Dashti R, Al Ozairi ES. Differences in physician compliance with guideline on lipid profile determination within 24 h after acute myocardial infarction. Med Princ Pract. 2005;14:41–5. 
21. Toyry J, Niskanen L, Mantysaari M, Lansimies E, Uusitupa M. Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM. Diabetes.1996; 45:308–315.
22. 22 Cheitlin MD, Armstrong WF, Aurigemma GP, et al.. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation 2003; 108:1146.
23. American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, et al.. Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance Endorsed by the American College of Chest Physicians. J Am Coll Cardiol 2011; 57:1126.
24. Kavsak PA, MacRae AR, Newman AM, et al.. Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure. Clin Biochem. 2007;40(5–6):326–329. doi:10.1016/j.clinbiochem.2006.10.025
25. Liu D, Qi X, Li Q, et al.. Increased complements and high-sensitivity C-reactive protein predict heart failure in acutemyocardial infarction. Biomed Rep. 2016;5(6):761–765. doi:10.3892/br.2016.793.